Free tool
Oncology stocks
We cover 5 companies grouped under the Oncology theme. The median market value in the group is $51.87M. Across the group, the median move over the past trading day is −2.11%. Price change over the past year runs from −83.8% to −34.7% across the middle 80 percent of the group, with a median of −48.9%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
5 of 319 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return | Next report |
|---|---|---|---|---|---|---|
| OSE.PA | OSE Immunotherapeutics SA | 3.19 EUR | +0.69% | −39.85% | −47.82% | Sep 28, 2026 |
| IMMP | Immutep Limited | $0.38 | +0.50% | −87.05% | −77.54% | Sep 2, 2026 |
| 0RAD.L | OSE Immunotherapeutics SA | 3.16 EUR | −2.11% | −40.40% | −48.92% | Sep 28, 2026 |
| BLRX | BioLineRx Ltd. | $2.85 | +1.06% | +1.79% | −25.97% | Aug 31, 2026 |
| LNAI | Lunai Bioworks Inc. | $2.20 | −1.35% | −71.71% | −87.99% | Sep 28, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.